Legitimate pain research is more crucial than ever japantimes.co.jp - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from japantimes.co.jp Daily Mail and Mail on Sunday newspapers.
Faye Flam
Better drugs to treat COVID-19 look more appealing than ever. The hope that vaccines would send the virus into retreat with herd immunity is fading as the more transmissible delta variant sweeps across the globe, cases rise, and the vaccine-hesitant millions dig in.
Beyond that, itâs unnerving to learn of even extremely rare cases where young, healthy people suffer and die from conditions possibly tied to vaccines: blood clots, heart inflammation and, most recently, the paralyzing disease known as Guillain-Barre syndrome.
Such rare but awful outcomes would seem more tolerable in a drug that cured the sick, and now that clinical studies have dampened enthusiasm for hydroxychloroquine, touted early in the pandemic by President Donald Trump, some scientists are pointing to promising studies of an anti-parasitic medicine called Ivermectin. Both drugs held particular appeal because they had already passed safety screening and were being used to combat other h
Long COVID-19 might help study of other chronic diseases taipeitimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from taipeitimes.com Daily Mail and Mail on Sunday newspapers.
Labeling misinformation online is doing more harm than good. The possibility that COVID-19 came from a lab accident is just the latest example. Social media companies tried to suppress any
Social media fact-checkers don’t have any special knowledge or ability to sort fact from misinformation. What they have is extraordinary power to shape what people believe.